A5199

International Neuropsychological Assessment of Patients Initiating Antiretroviral Therapy in Resource-Limited Settings

Sponsors:
US National Institute of Allergy and Infectious Diseases (NIAID)
US National Institute of Mental Health

Summary:
A5199 was a prospective, observational, international, multicenter study of cognitive impairment and dementia due to HIV (AIDS dementia complex [ADC]) and HIV-associated neurological opportunistic infections in participants with advanced disease in resource-limited settings who are enrolled in A5175

Years: 2005 – 2009

Investigator: James Hakim, MBChB, FRCP

Location: Parirenyatwa CRS

Comments are closed.